Autoimmune disorders can cause profound disruptions to the functioning of many systems daily. Sjogren’s syndrome affects the entirety of the body’s exocrine glands. One symptom of this chronic condition is the drying of mucosal tissues which can be an extreme strain on the patient. Sjogren’s syndrome patients experience the dual discomforts of drying in the eyes and in the oral cavity. This combination is often made worse by chronic fatigue. Systemic inflammation can spread and further worsen the quality of life of those patients. Management of symptoms could be better. Researchers are trying to find better regenerative medicine interventions to provide relaxation to patients for longer time frames. A singular stem cell clinic brings promising advancements due to the complexities of autoimmune disorders. Cellular therapies at the clinic work on reversing damages done to multiple glands. The exploration of clinical innovations and their applications is of the utmost importance. It is the only option to guarantee the restoration of health. Only true healing requires the abandonment of transitory and temporary medications.
2. Sjogren’s syndrome Mechanism
The pathophysiology of the Sjogren’s syndrome condition occurs when both the salivary and lacrimal glands are affected by an aggressive infiltration of lymphocytes. The first stage of the immunological assault is carried out by the CD4 positive T lymphocytes. Affected tissues next experience B lymphocyte hyperreactivity as a response to the damaged environment. Excess hyperreactivity of lymphocytes results in the production of autoantibodies which include a variety of destructive proteins of Ro/SSA and La/SSB. Several inflammatory cytokines can cause severe disruption and damage to the intracellular and interstitial structures of glands. Once the extracellular matrix is damaged due to matrix metalloproteinases, the acinar cells permanently lose their ability to perform secretory functions. The inflammation can cause the loss of aquaporin channels which limits the transport of fluids across biological membranes.
Elucidating biological pathways explains why surface symptom-suppressing treatments for Sjogren’s syndrome fail. Restoring equilibrium requires substantial cellular intervention. Deep cellular dysfunction cannot be repaired using superficial cellular interventions in stem cell clinic. Restoring equilibrium requires modulation of these hyperactive immune pathways.
Figure 1: Sjogren’s syndrome Mechanism
3. Conventional Sjogren’s syndrome Approaches
Immunosuppressive agents form the backbone of most conventional therapeutic regimens. Corticosteroids are only useful in the acute phase and do not help in the chronic phase of systemic flare-up. Some improvement in glandular function can be achieved with the use of artificial secretagogues, but are by no means a solution. Sufficient temporary relief of ocular surface irritation can be achieved with the use of lubricants. Disease-modifying antirheumatic drugs can be employed in an attempt to chemically decelerate the insidious progression of the disease. However, these modalities of pharmacotherapy have significant biological restrictions for the extended long-term treatment of Sjogren’s syndrome. The extensive use of immunosuppression contributes to increasing the vulnerability of the patient to even the most banal and most threatening opportunistic infections. The long-term use of Corticosteroids leads to complex metabolic disturbances and severe osteoporosis. Most importantly, the conventional approaches cannot physically reconstruct the damaged glandular architecture, whereas a specialized stem cell clinic can. The loss of cellular function cannot be treated using pharmaceuticals to just mask the symptoms. The plateauing of the patient’s condition is manifest in that all clinical effects of the medications are lost.
4. stem cell clinic
Specialized stem cell clinic are the only places to offer an intervention that is addressing the reason why the patient has the autoimmune dysfunction. The properties of these mesenchymal cells are beyond almost all cellular therapies. They have the ability to change ostensive paracrine factors to T-cells to Regulatory T-cells. With this rapid control of secretions, the rapid destruction of glandular tissues is halted. Rapid blood vessel growth and cellular replacement of tissues can also be achieved with these therapies.
Boosted capillary blood flow supplies nutrients to damaged acinar structures. The cellular secretome initiates tissue regeneration by targeting dormant progenitor cells. Apoptosis ceases as the body’s overall equilibrium is restored. The remodeling of fibrous tissue reverses to a more normal state through the controlled reduction of profibrotic cytokines. The application of these biological mechanisms presents an opportunity to address Sjogren’s syndrome at the molecular and microscopic levels. Therefore, cellular medicine provides a seamless transition to a more advanced therapy model that moves beyond the management of symptoms to a more structural repair of the body’s tissues.
Figure 2: Comparing of Conventional and Specialized stem cell clinic in Sjogren’s syndrome
5. Future Trends in Thailand
Southeast Asia is emerging as a major global center for new and innovative research in regenerative medicine. Thailand’s progressive regulatory system encourages medical innovation. Thailand’s world-class research infrastructure encourages rigorous clinical testing. Every major stem cell clinic in Thailand operates in strict compliance with rigorous international safety standards. The region’s medical tourism infrastructure is well-integrated with the biotechnological research facilities. Thai researchers are improving advanced techniques for the cultivation of stem cell populations derived from umbilical cords. The region’s tropical climate even reduces costs for the maintenance of advanced laboratory facilities. For the global patient seeking biological medicine alternatives, Thailand is the promising innovation center for cost-effective, high-quality, and complex regenerative medicine. The current trajectory indicates that Thai facilities will continue to pioneer individualized regenerative medicine for the treatment of complex autoimmune disorders of the highest global demand. Accordingly, Thailand’s emerging and innovative regenerative medicine is expected to affordably treat patients with Sjogren’s syndrome.